{"title":"Glucose Fuel Cells: Electricity from Blood Sugar.","authors":"Robert G Gloeb-McDonald, Gene Fridman","doi":"10.1109/RBME.2024.3368662","DOIUrl":null,"url":null,"abstract":"<p><p>Harvesting energy from the human body is an area of growing interest. While several techniques have been explored, the focus in the field is converging on using Glucose Fuel Cells (GFCs) that use glucose oxidation reactions at an anode and oxygen reduction reactions (ORRs) at a cathode to create a voltage gradient that can be stored as power. To facilitate these reactions, catalysts are immobilized at an anode and cathode that result in electrochemistry that typically produces two electrons, a water molecule, and gluconic acid. There are two competing classes of these catalysts: enzymes, which use organic proteins, and abiotic options, which use reactive metals. Enzymatic catalysts show better specificity towards glucose, whereas abiotic options show superior operational stability. The most advanced enzymatic test showed a maximum power density of 119 μW/cm<sup>2</sup> and an efficiency loss of 4% over 15 hours of operation. The best abiotic experiment resulted in 43 μW/cm<sup>2</sup> and exhibited no signs of performance loss after 140 hours. Given the range of existing implantable devices' power budget from 10μW to 100mW and expected operational duration of 10 years or more, GFCs hold promise, but considerable advances need to be made to translate this technology to practical applications.</p>","PeriodicalId":39235,"journal":{"name":"IEEE Reviews in Biomedical Engineering","volume":null,"pages":null},"PeriodicalIF":17.2000,"publicationDate":"2024-02-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"IEEE Reviews in Biomedical Engineering","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1109/RBME.2024.3368662","RegionNum":1,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0
Abstract
Harvesting energy from the human body is an area of growing interest. While several techniques have been explored, the focus in the field is converging on using Glucose Fuel Cells (GFCs) that use glucose oxidation reactions at an anode and oxygen reduction reactions (ORRs) at a cathode to create a voltage gradient that can be stored as power. To facilitate these reactions, catalysts are immobilized at an anode and cathode that result in electrochemistry that typically produces two electrons, a water molecule, and gluconic acid. There are two competing classes of these catalysts: enzymes, which use organic proteins, and abiotic options, which use reactive metals. Enzymatic catalysts show better specificity towards glucose, whereas abiotic options show superior operational stability. The most advanced enzymatic test showed a maximum power density of 119 μW/cm2 and an efficiency loss of 4% over 15 hours of operation. The best abiotic experiment resulted in 43 μW/cm2 and exhibited no signs of performance loss after 140 hours. Given the range of existing implantable devices' power budget from 10μW to 100mW and expected operational duration of 10 years or more, GFCs hold promise, but considerable advances need to be made to translate this technology to practical applications.
期刊介绍:
IEEE Reviews in Biomedical Engineering (RBME) serves as a platform to review the state-of-the-art and trends in the interdisciplinary field of biomedical engineering, which encompasses engineering, life sciences, and medicine. The journal aims to consolidate research and reviews for members of all IEEE societies interested in biomedical engineering. Recognizing the demand for comprehensive reviews among authors of various IEEE journals, RBME addresses this need by receiving, reviewing, and publishing scholarly works under one umbrella. It covers a broad spectrum, from historical to modern developments in biomedical engineering and the integration of technologies from various IEEE societies into the life sciences and medicine.